ORBIMED CAPITAL LLC

Director at Euthymics Bioscience, Inc. · on record since May 18, 2006
Director at GIVEN IMAGING LTD · on record since May 26, 2006
10% owner at GIVEN IMAGING LTD · on record since May 26, 2006
Director at MEMORY PHARMACEUTICALS CORP · on record since Apr 7, 2004
FN4 at MEMORY PHARMACEUTICALS CORP · on record since Apr 7, 2004
10% owner at CRYOCOR INC · on record since Jun 19, 2007
10% owner at AEROGEN INC · on record since May 17, 2004
10% owner at Euthymics Bioscience, Inc. · on record since Jul 16, 2003
10% owner at ORTHOVITA INC · on record since Sep 4, 2003
10% owner at ChemoCentryx, Inc. · on record since Feb 15, 2012
Director at Prelude Therapeutics Inc · on record since Apr 23, 2026
10% owner at Prelude Therapeutics Inc · on record since Apr 23, 2026
10% owner at LIFECELL CORP · on record since Dec 30, 2003
Director at Alector, Inc. · on record since Feb 11, 2019
10% owner at Alector, Inc. · on record since Feb 11, 2019
Director at Sierra Oncology, Inc. · on record since Nov 26, 2019
10% owner at Sierra Oncology, Inc. · on record since Nov 26, 2019
Director at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
10% owner at · on record since Jan 30, 2020
Director at · on record since Jun 25, 2020
Director at · on record since Sep 29, 2020
10% owner at · on record since Sep 29, 2020
Director at · on record since Jul 2, 2020
Director at · on record since Dec 9, 2020
10% owner at · on record since Dec 9, 2020
Director at · on record since Feb 19, 2021
10% owner at · on record since Feb 19, 2021
Director at · on record since May 6, 2005
Director at · on record since Jul 16, 2021
10% owner at · on record since Jul 16, 2021
Director at · on record since Aug 22, 2005
Director at · on record since Dec 8, 2020
10% owner at · on record since Dec 8, 2020

Insider trading activity of ORBIMED CAPITAL LLC

Transactions on record: 66; since Jan 14, 2004

Open-market buys: 8; $57.9M

Open-market sells: 26; $39.4M

Companies traded: 9; last filing Aug 28, 2024

Figures computed from official regulatory filings — .

Companies where ORBIMED CAPITAL LLC has traded

13 tx · $37.6M · Aug 28, 2024
1 tx · $5M · May 24, 2023
6 tx · $108.1M · Jul 1, 2022
14 tx · $27.7M · Apr 8, 2022
12 tx · $1.2M · Aug 30, 2021
12 tx · Dec 9, 2020
4 tx · $15.3M · Jul 2, 2020
3 tx · $7.4M · Jan 13, 2020
1 tx · $3.1M · Jan 14, 2004

Track record of ORBIMED CAPITAL LLC

Statistical track record

Free account

Open-market buys: 8

Last buy: May 22, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of ORBIMED CAPITAL LLC

Co-insiders of ORBIMED CAPITAL LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ARS Pharmaceuticals, Inc.Listing on record	Aug 28, 2024	Sell	-83,695	13.00 USD	$1.1M		SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-69,500	13.03 USD	$905.6K		SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-394,400	13.52 USD	$5.3M	Unusual size	SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-391,482	12.94 USD	$5.1M	Unusual size	SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-13,300	14.61 USD	$194.3K		SEC
Prelude Therapeutics IncListing on record	May 24, 2023	Buy	869,565	5.75 USD	$5M	conv 41First in 12mo	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-226,704	55.00 USD	$12.5M		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-170,437	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-170,437	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,136,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-226,704	55.00 USD	$12.5M		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-1,511,362	55.00 USD	$83.1M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-97,200	20.71 USD	$2M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-167,800	20.66 USD	$3.5M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-177,196	20.66 USD	$3.7M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-102,800	20.71 USD	$2.1M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-162,000	20.69 USD	$3.4M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-171,204	20.69 USD	$3.5M	Unusual size	SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-6,884	33.94 USD	$233.6K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-4,157	34.52 USD	$143.5K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-197	33.92 USD	$6.7K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-6,500	33.92 USD	$220.5K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-209	33.94 USD	$7.1K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-126	34.52 USD	$4.3K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 25, 2021	Sell	-119	34.07 USD	$4.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ARS Pharmaceuticals, Inc.Listing on record	Aug 28, 2024	Sell	-83,695	13.00 USD	$1.1M		SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-69,500	13.03 USD	$905.6K		SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-394,400	13.52 USD	$5.3M	Unusual size	SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-391,482	12.94 USD	$5.1M	Unusual size	SEC
ARS Pharmaceuticals, Inc.Listing on record	Aug 23, 2024	Sell	-13,300	14.61 USD	$194.3K		SEC
Prelude Therapeutics IncListing on record	May 24, 2023	Buy	869,565	5.75 USD	$5M	conv 41First in 12mo	SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-226,704	55.00 USD	$12.5M		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-170,437	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-170,437	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	OtherD (derivative)	-1,136,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-226,704	55.00 USD	$12.5M		SEC
Sierra Oncology, Inc.Listing unverified	Jul 1, 2022	Other	-1,511,362	55.00 USD	$83.1M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-97,200	20.71 USD	$2M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-167,800	20.66 USD	$3.5M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-177,196	20.66 USD	$3.7M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-102,800	20.71 USD	$2.1M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-162,000	20.69 USD	$3.4M		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Apr 8, 2022	Sell	-171,204	20.69 USD	$3.5M	Unusual size	SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-6,884	33.94 USD	$233.6K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-4,157	34.52 USD	$143.5K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-197	33.92 USD	$6.7K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-6,500	33.92 USD	$220.5K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-209	33.94 USD	$7.1K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 30, 2021	Sell	-126	34.52 USD	$4.3K		SEC
Repare Therapeutics Inc.Listing unverified	Aug 25, 2021	Sell	-119	34.07 USD	$4.1K		SEC